Chapter A Review of Compliant Movement Primitives

Neurodegenerative diseases are being modelled in-vitro using human patient-specific, induced pluripotent stem cells and transgenic embryonic stem cells to determine more about disease mechanisms, as well as to discover new treatments for patients. Current research in modelling Alzheimer’s disease, f...

Повний опис

Збережено в:
Бібліографічні деталі
Автори: Gams, Andrej, Ude, Ales, Petrič, Tadej, Denisa, Miha
Формат: Online
Мова:Англійська
Опубліковано: InTechOpen 2021
Предмети:
Онлайн доступ:ONIX_20210602_10.5772/64058_269
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
_version_ 1869530835371163648
author Gams, Andrej
Ude, Ales
Petrič, Tadej
Denisa, Miha
author_browse Denisa, Miha
Gams, Andrej
Petrič, Tadej
Ude, Ales
author_facet Gams, Andrej
Ude, Ales
Petrič, Tadej
Denisa, Miha
author_sort Gams, Andrej
collection Directory of Open Access Books
description Neurodegenerative diseases are being modelled in-vitro using human patient-specific, induced pluripotent stem cells and transgenic embryonic stem cells to determine more about disease mechanisms, as well as to discover new treatments for patients. Current research in modelling Alzheimer’s disease, frontotemporal dementia and Parkinson’s disease using pluripotent stem cells is described, along with the advent of gene-editing, which has been the complimentary tool for the field. Current methods used to model these diseases are predominantly dependent on 2D cell culture methods. Outcomes reveal that only some of the phenotype can be observed in-vitro, but these phenotypes, when compared to the patient, correlate extremely well. Many studies have found novel molecular mechanisms involved in the disease and therefore elucidate new potential targets for reversing the phenotype. Future research that includes studying more complex 3D cell cultures, as well as accelerating aging of the neurons, may help to yield stronger phenotypes in the cultured cells. Thus, the use and application of pluripotent stem cells for modelling disease have already shown to be a powerful approach for discovering more about these diseases, but will lead to even more findings in the future as gene and cell culture technology continues to develop.
format Online
id doab-20.500.12854ir-70469
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher InTechOpen
publisherStr InTechOpen
record_format ojs
spelling doab-20.500.12854ir-704692024-04-05T17:30:57Z Chapter A Review of Compliant Movement Primitives Gams, Andrej Ude, Ales Petrič, Tadej Denisa, Miha Disease modelling, Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, pluripotent stem cells thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSF Cellular biology (cytology) Neurodegenerative diseases are being modelled in-vitro using human patient-specific, induced pluripotent stem cells and transgenic embryonic stem cells to determine more about disease mechanisms, as well as to discover new treatments for patients. Current research in modelling Alzheimer’s disease, frontotemporal dementia and Parkinson’s disease using pluripotent stem cells is described, along with the advent of gene-editing, which has been the complimentary tool for the field. Current methods used to model these diseases are predominantly dependent on 2D cell culture methods. Outcomes reveal that only some of the phenotype can be observed in-vitro, but these phenotypes, when compared to the patient, correlate extremely well. Many studies have found novel molecular mechanisms involved in the disease and therefore elucidate new potential targets for reversing the phenotype. Future research that includes studying more complex 3D cell cultures, as well as accelerating aging of the neurons, may help to yield stronger phenotypes in the cultured cells. Thus, the use and application of pluripotent stem cells for modelling disease have already shown to be a powerful approach for discovering more about these diseases, but will lead to even more findings in the future as gene and cell culture technology continues to develop. 2021-02-10T12:58:18Z 2021-06-02T10:08:00Z 2016 chapter ONIX_20210602_10.5772/64058_269 https://library.oapen.org/handle/20.500.12657/49155 https://directory.doabooks.org/handle/20.500.12854/70469 eng open access image/jpeg image/jpeg n/a n/a https://library.oapen.org/bitstream/20.500.12657/49155/1/51122.pdf https://library.oapen.org/bitstream/20.500.12657/49155/1/51122.pdf InTechOpen 10.5772/64058 10.5772/64058 035ecc65-6737-43cf-a13a-6bdf67ce01f4 open access
spellingShingle Disease modelling, Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, pluripotent stem cells
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSF Cellular biology (cytology)
Gams, Andrej
Ude, Ales
Petrič, Tadej
Denisa, Miha
Chapter A Review of Compliant Movement Primitives
title Chapter A Review of Compliant Movement Primitives
title_full Chapter A Review of Compliant Movement Primitives
title_fullStr Chapter A Review of Compliant Movement Primitives
title_full_unstemmed Chapter A Review of Compliant Movement Primitives
title_short Chapter A Review of Compliant Movement Primitives
title_sort chapter a review of compliant movement primitives
topic Disease modelling, Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, pluripotent stem cells
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSF Cellular biology (cytology)
topic_facet Disease modelling, Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, pluripotent stem cells
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSF Cellular biology (cytology)
url ONIX_20210602_10.5772/64058_269
work_keys_str_mv AT gamsandrej chapterareviewofcompliantmovementprimitives
AT udeales chapterareviewofcompliantmovementprimitives
AT petrictadej chapterareviewofcompliantmovementprimitives
AT denisamiha chapterareviewofcompliantmovementprimitives